About Novartis Biome
Founded in 2018, the Novartis Biome is a catalyst for impactful collaboration. The Biome brings together Novartis’ deep scientific experience with the expertise of the tech ecosystem to develop and scale digital solutions that improve and extend people’s lives. The Biome allows internal and external teams to co-develop digital solutions alongside specific therapeutic offerings, research activities, and business processes within Novartis. Launched in 2020 striving to test and learn fast, the Novartis Biome UK is located in the heart of London, focusing on scaling innovative solutions for chronic and long-term disease management. To date, the Biome UK has successfully scouted, tested and scaled a digital patient management solution to help tackle the patient backlog called Penguin and successfully launched its first ever Evidence Lab test in a real clinical environment. For more information, please visit https://www.biome.novartis.com/
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), please visit http://www.medtronic.com/
About RYSE Asset Management
RYSE Asset Management (RYSE) is a specialist healthcare investor with a focus on impact. Since 2015, RYSE has been supporting technology companies to achieve accelerated global growth and scale by connecting high-potential healthcare founders with established distribution partners. In 2018/20, RYSE DigitalHealth. London investment programmes translated great ideas into real-world solutions. RYSE partners with founders with clinical experience who know how to serve patients best and with investors that share RYSE’s ambition to transform the future of healthcare, improving quality and access. For more information, please visit https://www.ryseam.com/en/ and follow us on LinkedIn.
About Chelsea and Westminster Hospital NHS Foundation Trust
Chelsea and Westminster Hospital NHS Foundation Trust is one of the top ranked and top performing hospital trusts in the UK. We employ more than 6,000 staff over our two main hospital sites, Chelsea and Westminster Hospital and West Middlesex University Hospital, and across 12 community-based clinics within North West London. We were rated Outstanding for Well-Led and Use of Resources by the Care Quality Commission.
Both hospitals have major A&E and urgent care departments, treating over 500,000 patients in a typical year. The Trust is one of the largest maternity services in England, delivering over 10,000 babies last year. Our specialist care includes the world-renowned burns service, which is the leading centre in London and the South East; we run Chelsea Children’s Hospital with paediatric inpatient and outpatient services; and our specialist HIV and award-winning sexual health care services.
In partnership with CW+ our hospital charity we build and enhance clinical facilities to create an outstanding care environment for our patients and for our staff.
We are an emerging leader for innovation within the NHS. Our CW Innovation programme is led jointly by the Trust and CW+ and has led to a number of successful projects adopted elsewhere in the NHS.
UK | June 2022 | 218979